Skip to main content
OpenTrials

Clinical trial condition

Ovarian Cancer

Explore clinical trials studying Ovarian Cancer. Study availability and eligibility vary by location and protocol.

1,443 public trials 326 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Cancer trial results

Completed

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma

NCT00531284

Conditions
Adnexal Diseases, Blood Protein Disorders, Bronchial Neoplasms, +47 more
Locations
  • Pinnacle Oncology Scottsdale, Arizona, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian Cancer

NCT01982500

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • University Hospital of Crete, Dep of Medical Oncology Heraklion, Crete, Greece
  • University General Hospital of Alexandroupolis, Dept. of Medical Oncology Alexandroupoli, Greece
  • "IASO" General Hospital of Athens Athens, Greece
  • Air Forces Military Hospital of Athens Athens, Greece
View Trial Details
Completed

Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinosis in Chemosensitive Patients

NCT01905163

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Institut de Cancerologie de l'Ouest, site Paul Papin Angers, France
  • CHU Estaing Clermont-Ferrand, France
  • Centre Jean Perrin Clermont-Ferrand, France
  • Institut Paoli Calmettes Marseille, France
View Trial Details
Completed

Pillars4Life Trial

NCT02465892

Conditions
Adnexal Diseases, Anxiety Disorders, Bladder Cancer, +71 more
Locations
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer

NCT00061308

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations
  • GSK Investigational Site Los Gatos, California, United States
  • GSK Investigational Site Santa Rosa, California, United States
  • GSK Investigational Site Washington D.C., District of Columbia, United States
  • GSK Investigational Site Hollywood, Florida, United States
View all 19 locations
View Trial Details
Completed

Assess Bioequivalence of Two Formulations of Doxorubicin Hydrochloride Liposome in Female Patients With Ovarian Cancer

NCT02237690

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Cancer Institute& Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • QiLu Hospital of Shandong University Jinan, Shandong, China
View Trial Details

Related conditions